Looking forward! "Traditional Chinese Medicine Law" is finally coming!

 

  November 23，Deputy Director of China National Health and Family Planning Commission、Director of the State Administration of Traditional Chinese Medicine Wang Guoqiang revealed in public， & ldquo; "Traditional Chinese Medicine Law" ("Chinese Medicine Law of the People's Republic of China"，The "Traditional Chinese Medicine Law" below) is about to be introduced。& rdquo;

 

  This means，"Traditional Chinese Medicine Law" will officially become the first national law drafted in my country，and foreseeable is，The Chinese medicine industry with a trillion -dollar market value will usher in a good benefit。

 

  Wang Guoqiang is at the 9th Global Health Promotion Conference Parallel Forum: TCM Development & RDQUO; announced this news，He also pointed out at the same time，The Chinese government has promoted the development of traditional Chinese medicine to the national strategic height。In recent months，Chinese medicine & ldquo; treatment & rdquo; also fully illustrates this。

 

  He thinks，The National Health and Health Conference pointed out that Chinese medicine is a medical science that has gradually developed and developed in the struggle of long -term production and life and disease in my country.，It is a system that has a unique theory and technical and technical methods in my country; "& ldquo; Healthy China 2030 & rdquo; Planning Outline" sets & ldquo;，Clarifying the key tasks of Chinese medicine，Mention Chinese medicine in many places at the same time，Integrate it into all aspects of health China。

 

  Wang Guoqiang disclosed further，In the legislation of Chinese medicine, the protection content of valuable Chinese medicinal materials has been taken into account，Also includes Stake Sports Bettingmedical Stake Sports Bettingtreatment、Culture、Private Hospital, etc.。Current，The draft of the National Traditional Chinese Medicine Law is soliciting opinions from various provinces and cities，If you go smoothly，It will be submitted to the National People's Congress as soon as possible for review。

 

  Although it will be introduced in the first half of the year，Wang Guoqiang said & ldquo;，But he also stated at the same time: & ldquo; We hope that the faster the faster the better & rdquo;。

 

  ▌ Chinese medicine & ldquo; bonus & rdquo; year

 

  Almost through the whole year of 2016，Chinese medicine industry densely ushered in policy dividends。

 

  February，The "Outline of Traditional Chinese Medicine Development Strategic Planning (2016-2030)" issued by the State Council is clearly proposed，By 2030，Traditional Chinese Medicine's health service capabilities have significantly enhanced & mdash; & mdash; & ldquo; synergy in the treatment of major diseases、The core role in the rehabilitation of the disease is fully exerted & rdquo;。

 

  At the end of July，National Administration of Traditional Chinese Medicine、The National Tourism Administration has jointly issued the "Exhibition Zone on the National Traditional Chinese Medicine Health Tourism Demonstration Zone (Base、Project) Creation of the creation work "，Plan for the next 3 years，Establish 10 countries in the country in the country、100 demonstration bases、1000 demonstration projects。

 

  August，The State Administration of Traditional Chinese Medicine officially issued "Development of TCM & LDQUO; 13th Five -Year Plan"，For the first time, raise the Chinese medicine industry to the status of the Chinese medicine industry to & ldquo;。

 

  The Planning further gives a clear growth target & mdash; & mdash; in the & ldquo; 125 & rdquo;，average annual increase of 19.92%; it is expected to be in the period of & ldquo; 135 & rdquo;，Enterprise business income above the size of Chinese medicine will still maintain a high speed，scale income is expected to reach 1582.3 billion yuan in 2020，Breakthrough trillion，The average annual growth rate will reach 15%。

 

　  Including the planned & ldquo; 135 & rdquo; Chinese medicine science and technology planning，Both are considered by the market and investment community to be regulatory and national strategic levels & ldquo; upgrade & rdquo;、Accelerate the Chinese medicine industry，and drive the Chinese medicine industry、Traditional Chinese Medicine Hospital、Chinese medicine、Preparation and Pharmaceutical、Important signal release of industrial upgrading in the field of medicinal materials and tourism。

 

  Research Report on the release of Xingye Securities，My stake betting appFor the medicine sector，In terms of event catalysis，stake betting appOn the one hand, pay attention to policies and good investment opportunities: Ru Xinjin Medical Insurance Variety、Large commercial enterprises under the two votes、CRO faucet released by the clinical trial base、Blood products enterprises in volume and price rise，In addition, some fundamentals are stable or upward，Companies driven by incidents such as incidents such as incidents are also the ideal choice from bottom -up layout。

 

  ▌ Do not do clinical，Classic Family & ldquo; Amnesty & rdquo;

 

  August this year，"Traditional Chinese Medicine Law (Draft)" second instance，Draft the second review of the draft further strengthened the planting and breeding of Chinese medicine materials、Traffic use and medical institutions Chinese medicine drinking tablets、Supervision and management of Chinese medicine preparations, etc.，Proposal to produce the eligible Chinese medicine compound preparations from the ancient classic famous prescriptions，When applying for a drug approval number，You can only provide non -clinical safety research materials。

 

  This undoubtedly simplifies the procedures for the listing of Chinese medicine for listing，Injecting a strong needle injection into related enterprises and industries。

 

  The second instance defined & ldquo;，refers to & ldquo; It is still widely used to this day、Exact effect、The prescriptions recorded in ancient Chinese medicine classics with obvious characteristics and advantages & rdquo;，The specific catalog will be formulated by the competent Chinese medicine department of the State Council and the drug supervision and management department。

 

  Public information display，Traditional Chinese Medicine Treatment Multi -purpose prescription，Nearly 100,000 prescriptions recorded in Chinese history，Among them, Niuhuang Qingxin Pill, one of the top ten famous medicines in Beijing Tongrentang, originated from the & ldquo of the Taiping Huimin and Dishuctic Pharmaceuticals in the Song Dynasty. Based on Yi folk medication，Experience of the Malaysian Medical Medicine，At the same time, drawing on the Chinese medicine classics such as "Compendium of Materia Medica" and "Southern Yunnan Materia Medica" in 1902。

 

  China has been continuing & mdash; & mdash; 1999，& ldquo; Basic research on key science issues of prescriptions & rdquo;，This is the first & ldquo; 973 & rdquo; project，A total of 8 research groups，Six -flavored Dihuang Fang、Fang Fang Dan Sinior、Qingkai Lingfang、Five classic famous prescriptions such as bloodfall and stake online sports bettingstasis are samples，Created a new model and related My stake betting apptechnologies for developing modern Chinese medicines guided by the theory of allocation of traditional Chinese medicine group。

 

   & ldquo; This regulation is quite scientific，and more in line with the actual situation。& rdquo; Wang Shuguang, a business partner of Gaotejia Medical Investment Group, believes in an interview with the media，& ldquo; The ancient classic celebrities have been proven to be effective after years of use，If re -verification and approval according to modern methods may not be scientific，Another will also cause waste of resources。Han Fang medicine in Japan has long adopted a similar approval method，The Japanese government stipulates that the prescription in the theory of typhoid fever can not be directly used as a clinical clinical。& rdquo;

 

  Cong Bin, deputy chairman of the Legal Committee of the National People's Congress, said when explaining to the conference，& ldquo;、Experts and pharmaceutical manufacturers propose，Chinese medicine approval shall meet the characteristics of traditional Chinese medicine，Eligible production of traditional Chinese medicine compound preparations that meet the conditions of production，It should be simplified for approval procedures，Encourage enterprises to develop and use traditional Chinese medicine resources。& rdquo;

 

  Academician of the Chinese Academy of Engineering、Chinese Medicine Pharmacist Li Lianda also thinks，In the development of new drugs，Chinese medicine and western medicine should indeed have their own review standards，& ldquo; completely apply western medicine standard，It's like judging Peking Opera with the standard of ballet，I am afraid this is not possible。& rdquo;

 

  ▌ 涨，Chinese medicine leading enterprise & ldquo; take off & rdquo;

 

  A series of high -frequency and high -standard policy stimulus，The Chinese medicine industry ushered in & ldquo; Dayangchun & rdquo;。

 

  Data display，2014 Chinese medicine production enterprises reached 3813，The total output value of the Chinese medicine industry is 730.2 billion yuan，and the country's attention to the Chinese medicine industry，Enterprises with the ability to develop innovation capabilities with drugs and high -end equipment and have high -quality imitation drugs。

 

  At the same time，Including East Ejiao、Tongrentang、Yunnan Baiyao，Tzura、、Kangmei Pharmaceutical and other traditional protection varieties and industry chain integration advantages leading company，All will benefit from policy dividends。

 

  In fact，Facing a series My stake betting appof policy adjustments in stake online sports bettingthe past two years，Representative companies have begun to lay out in advance。

 

  Public information display，Kangmei Pharmaceutical Smart Pharmacy has been officially launched since June 2015，Daily prescriptions have increased rapidly from 4,500 in the second quarter of this year to more than 12,000 or more，The month-on-month growth rate reached 30-40%，It is expected to achieve 30,000 pieces at the end of the year，Bringing more than 600 million Chinese medicine tablets incremental income & mdash; & mdash; this three -party win -win business model，Hospital saving cost、Patients save time、The company can exchange for the sales of Chinese medicine drinks，Metal logic is clear。

 

  and the core variety of Tasse of Tasses, which focus on the modernization of Chinese medicine, will soon complete the global multi -centered phase III clinical trial and complete it in advance，Multiple varieties are expected to enter the adjusted national medical insurance directory。